Literature DB >> 24675681

Prevalence, awareness, treatment and control of hypertension and salt intake in Portugal: changes over a decade. The PHYSA study.

Jorge Polonia1, Luis Martins, Fernando Pinto, Jose Nazare.   

Abstract

OBJECTIVE: To determine prevalence, awareness, treatment and control of hypertension and the 24-h sodium excretion (24h-UNa) in the Portuguese adult population and to examine their changes from a similar study done in 2003. DESIGN AND
SETTING: A population-based cross-sectional survey conducted in 2011-2012.
METHODS: A multistage-stratified (by age and sex) sampling method was used to select a representative sample of the 18-90-year-old population yielding 3720 participants (52.6% women, 97.1% Caucasians). Hypertension was defined as a SBP of at least 140  mmHg or DBP of at least 90  mmHg [average of 2-3 blood pressure (BP) measurements by trained observers with OMRON M6] or reported knowledge or treatment with antihypertensive drugs at the first visit (V1). A complete clinical information was obtained with a standard questionnaire. This procedure was repeated 10-15 days after visit 2 (V2) and 24-h urinary sample was collected for 24h-UNa, 24-h potassium excretion and creatinine excretion.
RESULTS: The overall prevalence of hypertension at V1 was 42.2% (44.4% in men, 40.2% in women) (42.1% in 2003). The age-specific prevalence of hypertension was 6.8, 46.9 and 74.9% in people below 35 years, 35-64 years and above 64 years. Comorbidities were 2.2-6.3 times more common in hypertensive patients vs. normotensive individuals. Overall, among the hypertensive patients, 76.6% were aware of the hypertension condition, 74.9% were treated and 42.5% were controlled (BP <140/90  mmHg), that is, respectively, 1.7, 1.9 and 3.8 times higher vs. data in 2003, with lower values in men vs. women and younger vs. older people. Global mean BP was 127.4/74.6 ± 17.7/10.5 vs. 134.7/80.4 ± 21.2/14.1  mmHg in 2003. From V1 to V2, control of hypertension increased on average by 14.8%. Multivariate analysis showed that age and BMI were independently associated with prevalence of hypertension. 24h-UNa (84% valid urinary samples) was 182.5 ± 64.7  mmol/day (10.7  g salt/day) and 24-h potassium excretion 75.2 ± 26.1  mmol/day. 24h-UNa was higher in patients with hypertension than in normotensive individuals (185.4 ± 64.8 vs. 177.8 ± 64.5  mmol/day; P < 0.02) and correlated with SBP (r = 0.05), age (r = 0.08) and BMI (r = 0.10) (P < 0.01).
CONCLUSION: Hypertension prevalence among Portuguese adults remained stable in the past decade, but proportions of awareness, treatment and control of hypertension improved significantly. Salt intake is still high being almost double the WHO recommendations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24675681     DOI: 10.1097/HJH.0000000000000162

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  38 in total

Review 1.  High salt intake as a multifaceted cardiovascular disease: new support from cellular and molecular evidence.

Authors:  Marcelo Perim Baldo; Sérgio Lamêgo Rodrigues; José Geraldo Mill
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

Review 2.  Population-level interventions in government jurisdictions for dietary sodium reduction.

Authors:  Lindsay McLaren; Nureen Sumar; Amanda M Barberio; Kathy Trieu; Diane L Lorenzetti; Valerie Tarasuk; Jacqui Webster; Norman Rc Campbell
Journal:  Cochrane Database Syst Rev       Date:  2016-09-16

3.  Hypertension and longevity: role of genetic polymorphisms in renin-angiotensin-aldosterone system and endothelial nitric oxide synthase.

Authors:  Alda Pereira da Silva; Andreia Matos; Laura Aguiar; Nuno Ramos-Marques; Ricardo Ribeiro; Ângela Gil; João Gorjão-Clara; Manuel Bicho
Journal:  Mol Cell Biochem       Date:  2018-11-20       Impact factor: 3.396

4.  Gender and obesity modify the impact of salt intake on blood pressure in children.

Authors:  Liane Correia-Costa; Dina Cosme; Luís Nogueira-Silva; Manuela Morato; Teresa Sousa; Cláudia Moura; Cláudia Mota; António Guerra; António Albino-Teixeira; José Carlos Areias; Franz Schaefer; Carla Lopes; Alberto Caldas Afonso; Ana Azevedo
Journal:  Pediatr Nephrol       Date:  2015-09-29       Impact factor: 3.714

5.  Characteristics Associated With Antihypertensive Treatment and Blood Pressure Control: A Population-Based Follow-Up Study in Peru.

Authors:  J Alfredo Zavala-Loayza; Catherine Pastorius Benziger; María Kathia Cárdenas; Rodrigo M Carrillo-Larco; Antonio Bernabé-Ortiz; Robert H Gilman; William Checkley; J Jaime Miranda
Journal:  Glob Heart       Date:  2016-03

Review 6.  Changes in Hypertension Prevalence, Awareness, Treatment, and Control in High-, Middle-, and Low-Income Countries: An Update.

Authors:  Renata Cifkova; George Fodor; Peter Wohlfahrt
Journal:  Curr Hypertens Rep       Date:  2016-08       Impact factor: 5.369

Review 7.  The Science of Salt: Updating the evidence on global estimates of salt intake.

Authors:  Sudhir Raj Thout; Joseph Alvin Santos; Briar McKenzie; Kathy Trieu; Claire Johnson; Rachael McLean; JoAnne Arcand; Norman R C Campbell; Jacqui Webster
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-04-29       Impact factor: 3.738

8.  Measurement of arterial stiffness and vascular aging in community pharmacies-The ASINPHAR@2action project.

Authors:  Telmo Pereira; Ema Paulino; Sofia Maximiano; Mariana Rosa; Ana Luísa Pinto; Maria João Mendes; Joana Brito; Patrícia Soares; Johannes Risse; Sonja Gose
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-05-16       Impact factor: 3.738

9.  Sex-specific patterns in the association between salt intake and blood pressure: The ELSA-Brasil study.

Authors:  José Geraldo Mill; Marcelo P Baldo; Maria Del Carmen B Molina; Maria Inês Schmidt; Sandhi M Barreto; Dora Chor; Rosane H Griep; Sheila M Matos; Antonio Luiz P Ribeiro; Bruce B Duncan; Estela M Aquino; Paulo A Lotufo; Isabela Bensenor
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-03-12       Impact factor: 3.738

10.  Patterns of hypertension management in France in 2015: The ESTEBAN survey.

Authors:  Alexandre Vallée; Amélie Gabet; Clémence Grave; Emmanuel Sorbets; Jacques Blacher; Valérie Olié
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-02-24       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.